… Patients in the bivalirudin group were subsequently randomly assigned to receive or not to
… bivalirudin infusion. Primary outcomes for the comparison between bivalirudin and heparin …

… This study assessed the efficacy and safety of bivalirudin compared with UFH with or without
GPIs in patients with acute coronary syndrome (ACS) who underwent invasive management…

… patients and number of patients in the bivalirudin and UFH groups, the doses in the
bivalirudin … UFH group, and the incidence of thromboses, major bleeding, and mortality (per-patient). …

… efficacy and safety of bivalirudin versus heparin in patients … and safety of bivalirudin
compared with heparin in patients … and safety of bivalirudin compared with heparin in patients …

… found that low doses of bivalirudin were required in patients with renal dysfunction or those
… study, we recommended starting bivalirudin at 0.03–0.05 mg/kg/hour in patients with renal or …

… Bivalirudin is an alternative to heparin in patients undergoing percutaneous coronary …
define the effects of a bivalirudin-based anticoagulation regimen compared with a heparin-based …

… Thus, bivalirudin appeared to be at least as effective as heparin in preventing ischemic …
Twenty-one institutions enrolled 101 patients randomized to bivalirudin and 49 to heparin with …

… observed with bivalirudin (6.9% vs 5.9%, p = 0.07, p het = 0.65). Bivalirudin was associated
… This meta-analysis shows that among patients undergoing coronary angioplasty, bivalirudin …

… on the safety and tolerability of bivalirudin in patients with CAD in the … of bivalirudin and its
efficacy, with special emphasis on its … Thus, switching from heparin to bivalirudin is a safe and …

… The aim of this study was to assess the impact of bivalirudin, as compared to unfractionated
heparin, on clinical outcomes in patients with ST-segment elevation myocardial infarction (…